The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells

This publication has 22 references indexed in Scilit:

• Vaccination with theChlamydia trachomatisMajor Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria
  Infection and Immunity, 2005
• Production of a Proteolytically Active Protein, Chlamydial Protease/Proteasome-Like Activity Factor, by Five Different Chlamydia Species
  Infection and Immunity, 2005
• Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine
  Nature Reviews Immunology, 2005
• Human Antibody Responses to a Chlamydia-Secreted Protease Factor
  Infection and Immunity, 2004
• Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice
  Cellular Immunology, 2004
• Fc Receptor–Mediated Antibody Regulation of T Cell Immunity against Intracellular Pathogens
  The Journal of Infectious Diseases, 2003
• Fc receptor regulation of protective immunity against Chlamydia trachomatis
  Immunology, 2002
• Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity againstStreptococcus pneumoniaeInfection
  Infection and Immunity, 2001
• Degradation of Transcription Factor Rfx5 during the Inhibition of Both Constitutive and Interferon γ–Inducible Major Histocompatibility Complex Class I Expression in Chlamydia-Infected Cells
  The Journal of Experimental Medicine, 2000
• Intranasal Interleukin‐12 is a Powerful Adjuvant for Protective Mucosal Immunity
  The Journal of Infectious Diseases, 1999